Stoke Therapeutics Inc STOK:NASDAQ

Set AlertOptionsStreaming Charts
Last Price$14.89NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22

Today's Change+1.17(8.53%)
Bid (Size)$10.17 (1)
Ask (Size)$27.00 (4)
Day Low / High$13.77 - 15.48
Volume375.0 K
Sell
Buy
Chart Style Historical Chart Icon Download historical data
 

View Biotechnology IndustryPeer Comparison as of 05/13/2022

Timeframe
 

Stoke Therapeutics Inc ( NASDAQ )

Price: $14.89
Change: +1.17 (8.53%)
Volume: 375.0 K
4:00PM ET 5/13/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

Sangamo Therapeutics Inc ( NASDAQ )

Price: $4.02
Change: +0.24 (6.35%)
Volume: 9.00
4:00PM ET 5/13/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

AnaptysBio Inc ( NASDAQ )

Price: $21.13
Change: -0.08 (0.38%)
Volume: 875.8 K
4:00PM ET 5/13/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

Rocket Pharmaceuticals Inc ( NASDAQ )

Price: $9.09
Change: +1.05 (13.06%)
Volume: 851.9 K
4:00PM ET 5/13/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

Sorrento Therapeutics Inc ( NASDAQ )

Price: $1.43
Change: +0.13 (10.00%)
Volume: 98.00
4:00PM ET 5/13/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain

Read more news Recent News

--Credit Suisse Lowers Stoke Therapeutics' Price Target to $54 from $58, Keeps Outperform Rating
10:41AM ET 5/11/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Wedbush Adjusts Price Target for Stoke Therapeutics to $33 From $32, Maintains Outperform Rating
2:51PM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

BofA Securities Adjusts Stoke Therapeutics' Price Target to $40 from $43, Keeps Buy Rating
11:12AM ET 3/16/2022 MT Newswires

Stoke Therapeutics (STOK) has an average rating of buy and price targets ranging from $32 to $83, according to analysts polled by Capital IQ. (MT Newswires...

--Wedbush Adjusts Stoke Therapeutics' Price Target to $32 From $48; Outperform Rating Kept
10:09AM ET 3/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

Stoke Therapeutics (STOK) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
2:22PM ET 1/24/2022 Seeking Alpha

Stoke Therapeutics (STOK) Investor Presentation -Slideshow
2:11AM ET 12/01/2021 Seeking Alpha

Company Profile

Business DescriptionStoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA. View company web site for more details
Address45 Wiggins Avenue
Bedford, Massachusetts 01730
Phone+1.781.430.8200
Number of EmployeesN/A
Chief Executive Officer & DirectorEdward M. Kaye
Chief Operating & Business OfficerHuw M. Nash
Chief Financial OfficerStephen J. Tulipano
Chief Medical OfficerBarry S. Ticho

Company Highlights

Price Open$14.26
Previous Close$14.89
52 Week Range$12.59 - 41.60
Market Capitalization$582.8 M
Shares Outstanding39.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.34
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-34.92%

Analyst Ratings as of 03/17/2022

Buy
11
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset